Cargando…
Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
Patients with metastatic triple‐negative breast cancer (TNBC) have a poor prognosis, so new therapies or drug combinations that achieve more effective and durable responses are urgently needed. Here, a combination therapy using cowpea mosaic virus (CPMV) and low doses of cyclophosphamide (CPA) is de...
Autores principales: | Cai, Hui, Wang, Chao, Shukla, Sourabh, Steinmetz, Nicole F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702650/ https://www.ncbi.nlm.nih.gov/pubmed/31453050 http://dx.doi.org/10.1002/advs.201802281 |
Ejemplares similares
-
Slow‐Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer
por: Czapar, Anna E., et al.
Publicado: (2018) -
S100A9‐Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma
por: Chung, Young Hun, et al.
Publicado: (2021) -
Cowpea Mosaic Virus
por: Lomonossoff, G.P.
Publicado: (2008) -
Radiation Therapy Combined with Cowpea Mosaic Virus
Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression
por: Patel, Ravi, et al.
Publicado: (2018) -
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
por: Lizotte, P. H., et al.
Publicado: (2015)